Stock Events

Stock Events

Khiron Life Sciences 

€0.032000
0
+€0.00+0%Friday 06:00

Statistics

Day High
0.032
Day Low
0.032
52W High
0.032
52W Low
0.032
Volume
8,000
Avg. Volume
0
Mkt Cap
6.95M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-260.64%Profit Margin
Unprofitable
2016
2017
2018
2019
2020
2021
8.76MRevenue
-22.83MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Canopy Growth
CGC
Mkt Cap276.03M
Canopy Growth Corporation is a leading cannabis company with a wide range of medical and recreational products, competing directly in markets served by Khiron.
Aurora Cannabis
ACB
Mkt Cap257.04M
Aurora Cannabis is involved in the cultivation, distribution, and sale of cannabis for medical and consumer use, similar to Khiron's business model.
Tilray Brands
TLRY
Mkt Cap373.9M
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, making it a direct competitor in multiple markets.
Cronos Group
CRON
Mkt Cap1.22B
Cronos Group operates globally in the cannabis industry, directly competing with Khiron in both medical and recreational sectors.
Curaleaf
CURLF
Mkt Cap2.5B
Curaleaf Holdings operates in the U.S. and competes with Khiron by offering a range of cannabis products in medical and wellness sectors.
Green Thumb Industries
GTBIF
Mkt Cap1.56B
Green Thumb Industries produces and sells a variety of cannabis products for medical and recreational use, competing in similar markets as Khiron.

About

Khiron Life Sciences Corp. operates as a comprehensive medical and cannabis enterprise, extending its operations across Latin America and Europe. The company's business is structured into three primary segments: Health Services, Medical Cannabis Products, and Wellbeing Products. A core focus for Khiron involves the end-to-end process of medical cannabis, encompassing the cultivation, manufacturing, distribution, and international export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) varieties. Additionally, the company manages a network of health centers and satellite clinics, notably under the ILANS and Zerenia brands. It also develops CBD-based cosmeceutical items, specifically marketed under its Kuida brand. Its healthcare footprint includes running Zerenia clinics in key locations such as Medellin and Peru. Khiron Life Sciences Corp. was founded in 2012 and maintains its corporate headquarters in Vancouver, Canada.
Show More
CEO
Alvaro Francisco Torres
Employees
310
Country
Canada
ISIN
CA49374L3065
WKN
000A2JMZC

Listings

STU
DE
4KH.STU
MU
DE
4KH.MU
OTC Link
US
KHRNF

0 Comments

Share your thoughts

FAQs

What is Khiron Life Sciences stock price today?▼
The current price of 4KH.MU is €0.03 EUR — it has increased by +0% in the past 24 hours. Watch Khiron Life Sciences stock price performance more closely on the chart.
What is Khiron Life Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Khiron Life Sciences stocks are traded under the ticker 4KH.MU.
What is Khiron Life Sciences market cap?▼
Today Khiron Life Sciences has the market capitalization of 6.95M
What is Khiron Life Sciences revenue for the last year?▼
Khiron Life Sciences revenue for the last year amounts to 8.76M EUR.
What is Khiron Life Sciences net income for the last year?▼
4KH.MU net income for the last year is -22.83M EUR.
How many employees does Khiron Life Sciences have?▼
As of November 2, 2026, the company has 310 employees.
In which sector is Khiron Life Sciences located?▼
Khiron Life Sciences operates in the Health & Wellness sector.
When did Khiron Life Sciences complete a stock split?▼
The last stock split for Khiron Life Sciences was on May 24, 2018 with a ratio of 1:8.
Where is Khiron Life Sciences headquartered?▼
Khiron Life Sciences is headquartered in Vancouver, Canada.